Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-18

Clinical Trial Update: Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial(HERO -aCKD) [Phase 4]

View source ↗

Summary

This clinical trial update describes the Phase 4 multicenter randomized HERO-aCKD study evaluating the effect of henagliflozin on renal outcomes in adults with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Henagliflozin (henagliflozin)

Snippet

Sponsor: First Affiliated Hospital of Wannan Medical College | Conditions: Chronic Kidney Disease Stage 4 | Phase 4 | Status: NOT_YET_RECRUITING